ZTS Q1 2019 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.5B+6.5% YoY

Gross Profit

$899M61.8% margin

Operating Income

$428M29.4% margin

Net Income

$312M21.4% margin

EPS (Diluted)

$0.65

QoQ Revenue Growth

-7.0%

Cash Flow

Operating Cash Flow

$389M

Free Cash Flow

$326M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$10.9B

Total Liabilities

$8.6B

Stockholders' Equity

$2.3B

Cash & Equivalents

$1.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.4B	+6.5%
Gross Profit	$899M	$896M	+0.3%
Operating Income	$428M	$461M	-7.2%
Net Income	$312M	$352M	-11.4%

Revenue Segments

Dogs and Cats

$688M48%

Cattle

$380M27%

Swine

$149M10%

Poultry

$139M10%

Horses

$41M3%

Fish

$23M2%

Geographic Segments

UNITED STATES

$718M72%

CHINA

$60M6%

BRAZIL

$60M6%

CANADA

$41M4%

GERMANY

$37M4%

FRANCE

$32M3%

ITALY

$28M3%

SPAIN

$27M3%